» Articles » PMID: 33936269

Prevalence of Gene Mutations Correlated to Presence of Clinical and Environmental Risk Factors in the Etiology of Congenital Sensorineural Hearing Loss of the Romanian Population

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2021 May 3
PMID 33936269
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Although etiologically heterogeneous at least 50% of all early on-set hearing losses have a genetic cause and of these, the large majority, 75-80% are most probably autosomal recessive and 70% are non-syndromic. The rest of the congenital hearing losses are determined by clinical and environmental factors such as ototoxic medication, prematurity, and complications at birth. During the last decade it became clear that 50-80% of all such afflictions result from mutations in a single gene, , which encodes the protein Connexin 26. In order to, at least partially clarify this problem, especially in an emerging country such as Romania, where the problem is not studied adequately, we developed a comprehensive study of genetic, clinical and environmental risk factors for congenital hearing loss. The two most common variations of this gene, and in children with positive diagnosis of bilateral severe to profound sensorineural hearing loss were investigated. A cohort of 34 children (20 female and 14 male), ages between 2 and 10 (mean age 4.62 years), coming from 33 non-related families were evaluated. All cases were diagnosed with severe or profound bilateral congenital SNHL. A statistical comparison of genetic and environmental/clinical prevalence was also attempted since the presence of a genetic disorder cannot rule out the role of other documented risk factors in the etiology of SNHL. The results showed that, 29.4% of cases (10/34) were homozygotic for the mutation ), also known as genotype Δ/Δ. 5.88% of cases (2/34) belong to the heterozygotic bi-genic group . The clinical factors with high statistical significance for SNHL in a non-genetic group have no significance for genetic SNHL patients. Thus, the present study confirms the relatively high prevalence of the and mutations in cases of congenital non-syndromic severe of profound bilateral SNHL.

Citing Articles

Burden of rare genetic disorders in India: twenty-two years' experience of a tertiary centre.

Sheth J, Nair A, Sheth F, Ajagekar M, Dhondekar T, Panigrahi I Orphanet J Rare Dis. 2024; 19(1):295.

PMID: 39138584 PMC: 11323464. DOI: 10.1186/s13023-024-03300-z.


Materials for ossicular chain reconstruction: History and evolution (Review).

Mocanu H, Mocanu A, Dascalu I, Schipor M, Radulescu M Med Int (Lond). 2023; 3(2):13.

PMID: 36875817 PMC: 9982808. DOI: 10.3892/mi.2023.73.


Non-Syndromic Hearing Loss in a Romanian Population: Carrier Status and Frequent Variants in the Gene.

Riza A, Alkhzouz C, Farcas M, Pirvu A, Miclea D, Mihut G Genes (Basel). 2023; 14(1).

PMID: 36672810 PMC: 9858611. DOI: 10.3390/genes14010069.


Rare Gene Mutations in Romanian Hypoacusis Patients: Case Series and a Review of the Literature.

Neagu A, Budisteanu M, Gheorghe D, Mocanu A, Mocanu H Medicina (Kaunas). 2022; 58(9).

PMID: 36143929 PMC: 9501263. DOI: 10.3390/medicina58091252.


Rare and unusual benign tumors of the sinonasal tract and pharynx: Case series and literature review.

Mocanu H, Mocanu A, Moldovan C, Soare I, Postolache P, Nechifor A Exp Ther Med. 2022; 23(5):334.

PMID: 35401795 PMC: 8987923. DOI: 10.3892/etm.2022.11263.


References
1.
Gasparini P, Rabionet R, Barbujani G, Melchionda S, Petersen M, Brondum-Nielsen K . High carrier frequency of the 35delG deafness mutation in European populations. Genetic Analysis Consortium of GJB2 35delG. Eur J Hum Genet. 2000; 8(1):19-23. DOI: 10.1038/sj.ejhg.5200406. View

2.
Palmer C, Lueddeke J, Zhou J . Factors influencing parental decision about genetics evaluation for their deaf or hard-of-hearing child. Genet Med. 2009; 11(4):248-55. PMC: 2822638. DOI: 10.1097/GIM.0b013e318195aad9. View

3.
Schimmenti L, Martinez A, Fox M, Crandall B, Shapiro N, Telatar M . Genetic testing as part of the early hearing detection and intervention (EHDI) process. Genet Med. 2004; 6(6):521-5. DOI: 10.1097/01.gim.0000144187.21727.28. View

4.
Bitner-Glindzicz M . Hereditary deafness and phenotyping in humans. Br Med Bull. 2002; 63:73-94. DOI: 10.1093/bmb/63.1.73. View

5.
Zelante L, Gasparini P, Estivill X, Melchionda S, DAgruma L, Govea N . Connexin26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. Hum Mol Genet. 1997; 6(9):1605-9. DOI: 10.1093/hmg/6.9.1605. View